Skip to main content

UBS Group AG

Position in GKOS — GLAUKOS Corp

CIK 1610520 ZURICH, V8

Position in GKOS

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$41,599,823
-$57,076,967 QoQ
Shares Held
386,400
-55.8% QoQ
Ownership
0.658%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96.49844720496894.ToString("F0")% Shared 0.ToString("F0")% None 3.501552795031056.ToString("F0")%

Common Shares in GKOS Over Time

Shares Held

Position Value (USD)

Derivatives in GKOS

reported options exposure · as of Jun 30, 2025
CallValue
$785,004
CallShares
7,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

UBS Group AG holds $5,239,528,751 across 130 Medical Devices names. GKOS ranks #16 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GKOS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $41,599,823 386,400
2025-12-31 $98,676,790 873,942
2025-09-30 $17,133,083 210,093
2025-06-30 $15,786,843 152,840
2025-06-30 $785,004 7,600
2025-03-31 $7,711,795 78,356
2024-12-31 $9,446,668 63,003
2024-09-30 $3,231,724 24,806
2024-06-30 $2,083,669 17,606
2024-03-31 $3,553,034 37,682
2023-12-31 $2,950,270 37,115
2023-09-30 $524,567 6,971
2023-06-30 $2,893,973 40,640
2023-03-31 $1,321,838 26,384
2022-12-31 $827,560 18,946
2022-09-30 $443,755 8,335
2022-06-30 $74,261 1,635
2022-03-31 $98,120 1,697
2021-12-31 $611,005 13,749
2021-09-30 $1,113,978 23,126
2021-06-30 $260,851 3,075
2021-03-31 $1,761,858 20,992
2020-12-31 $646,708 8,593
2020-09-30 $77,696 1,569
2020-06-30 $57,053 1,485
2020-03-31 $432,564 14,017